Larson CM, Giveans MR, Samuelson KM, Stone RM, Bedi A Arthroscopic Hip Revision Surgery for Residual Femoroacetabular Impingement (FAI): Surgical Outcomes Compared With a Matched Cohort After Primary Arthroscopic FAI Correction. Am J Sports Med. 2014 Aug;42(8):1785-90. doi: 10.1177/0363546514534181. Epub 2014 May 29.
Mansor Y, Perets I, Close MR, Mu BH, Domb BG In Search of the Spherical Femoroplasty: Cam Overresection Leads to Inferior Functional Scores Before and After Revision Hip Arthroscopic Surgery. Am J Sports Med. 2018 Jul;46(9):2061-2071. doi: 10.1177/0363546518779064. Epub 2018 Jun 20.
Matsuda DK, Schnieder CP, Sehgal B The critical corner of cam femoroacetabular impingement: clinical support of an emerging concept. Arthroscopy. 2014 May;30(5):575-80. doi: 10.1016/j.arthro.2014.01.009. Epub 2014 Mar 12.
Ross JR, Larson CM, Adeoye O, Kelly BT, Bedi A Residual deformity is the most common reason for revision hip arthroscopy: a three-dimensional CT study. Clin Orthop Relat Res. 2015 Apr;473(4):1388-95. doi: 10.1007/s11999-014-4069-9. Erratum In: Clin Orthop Relat Res. 2015 Mar;473(3):1167. Adeoyo, Olusanjo [corrected to Adeoye, Olusanjo].
Prospective Randomized Controlled Study Utilizing the Stryker Hip-Check Software Platform
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
